Peter D. Block

605 total citations
17 papers, 457 citations indexed

About

Peter D. Block is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Peter D. Block has authored 17 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Immunology. Recurrent topics in Peter D. Block's work include Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (5 papers). Peter D. Block is often cited by papers focused on Hepatitis B Virus Studies (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis C virus research (5 papers). Peter D. Block collaborates with scholars based in United States, India and United Kingdom. Peter D. Block's co-authors include Yuchen Xia, T. Jake Liang, Xiaoming Cheng, Thomas R. Kelly, Elisavet Serti, Kazuaki Chayama, Barbara Rehermann, Michelle Chung, Yao Zhao and Ulrike Protzer and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Virology.

In The Last Decade

Peter D. Block

16 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter D. Block United States 8 230 197 103 79 76 17 457
Jeffrey Quinn United States 11 273 1.2× 258 1.3× 101 1.0× 110 1.4× 21 0.3× 19 469
Megumi Tasaka‐Fujita Japan 7 143 0.6× 149 0.8× 114 1.1× 193 2.4× 13 0.2× 9 422
Patricia Baré Argentina 16 228 1.0× 226 1.1× 94 0.9× 173 2.2× 27 0.4× 46 665
Françoise Stoll‐Keller France 19 581 2.5× 666 3.4× 106 1.0× 151 1.9× 31 0.4× 46 915
Mark A. A. Claassen Netherlands 12 233 1.0× 249 1.3× 19 0.2× 224 2.8× 20 0.3× 30 488
Simon Hellier United Kingdom 8 416 1.8× 498 2.5× 79 0.8× 232 2.9× 24 0.3× 9 780
A. M. J. Wensing Netherlands 11 163 0.7× 70 0.4× 81 0.8× 89 1.1× 15 0.2× 22 442
Bridget M. Donovan United States 7 270 1.2× 320 1.6× 91 0.9× 125 1.6× 19 0.3× 7 540
María Cristina Navas Colombia 17 425 1.8× 423 2.1× 124 1.2× 79 1.0× 60 0.8× 66 777
Matthieu Blanchet Canada 12 447 1.9× 379 1.9× 72 0.7× 58 0.7× 44 0.6× 19 550

Countries citing papers authored by Peter D. Block

Since Specialization
Citations

This map shows the geographic impact of Peter D. Block's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter D. Block with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter D. Block more than expected).

Fields of papers citing papers by Peter D. Block

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter D. Block. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter D. Block. The network helps show where Peter D. Block may publish in the future.

Co-authorship network of co-authors of Peter D. Block

This figure shows the co-authorship network connecting the top 25 collaborators of Peter D. Block. A scholar is included among the top collaborators of Peter D. Block based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter D. Block. Peter D. Block is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Block, Timothy M., Ju‐Tao Guo, Fabien Zoulim, et al.. (2025). New potent HBV replication inhibitors for the management of chronic hepatitis B are needed. Nature Reviews Gastroenterology & Hepatology. 22(3). 150–151. 4 indexed citations
2.
Block, Peter D., Camilla S. Graham, Mark Sulkowski, et al.. (2025). Sexual health and young people living with chronic hepatitis B: adopting a treatment as prevention framework. ˜The œLancet. Gastroenterology & hepatology. 10(7). 609–612.
3.
Block, Peter D., Mario Strazzabosco, & Ariel Jaffe. (2024). Approach to immunotherapy for HCC in the liver transplant population. Clinical Liver Disease. 23(1). e0158–e0158. 2 indexed citations
4.
Lin, Selena Y., Dina Halegoua‐De Marzio, Peter D. Block, et al.. (2023). Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study. Diagnostics. 13(9). 1537–1537. 2 indexed citations
5.
Block, Peter D. & Joseph K. Lim. (2023). Chronic Hepatitis B Virus: What an Internist Needs to Know. Medical Clinics of North America. 107(3). 435–447. 6 indexed citations
6.
Block, Peter D., et al.. (2021). Acute Esophageal Necrosis Secondary to a Paraesophageal Hernia. SHILAP Revista de lepidopterología. 15(2). 594–597. 4 indexed citations
7.
Block, Peter D., et al.. (2020). Vagaries of the Host Response in the Development of Hepatitis B-related Hepatocellular Carcinoma: A Case Series. Current Cancer Therapy Reviews. 16(3). 253–258. 7 indexed citations
8.
Block, Peter D., et al.. (2020). Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes. SHILAP Revista de lepidopterología. 8(1). HEP35–HEP35. 5 indexed citations
9.
Cheng, Xiaoming, Yuchen Xia, Elisavet Serti, et al.. (2017). Hepatitis B virus evades innate immunity of hepatocytes but activates cytokine production by macrophages. Hepatology. 66(6). 1779–1793. 123 indexed citations
10.
Muthumani, Kar, Peter D. Block, Seleeke Flingai, et al.. (2016). Rapid and Long-Term Immunity Elicited by DNA-Encoded Antibody Prophylaxis and DNA Vaccination Against Chikungunya Virus. The Journal of Infectious Diseases. 214(3). 369–378. 69 indexed citations
11.
Xia, Yuchen, Arnaud Carpentier, Xiaoming Cheng, et al.. (2016). Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions. Journal of Hepatology. 66(3). 494–503. 103 indexed citations
12.
Muthumani, Kar, Peter D. Block, Seleeke Flingai, et al.. (2016). Synthetic DNA encoded antibody prophylaxis confers rapid protective immunity in vivo against Chikungunya virus infection. International Journal of Infectious Diseases. 45. 185–185. 1 indexed citations
13.
Wang, Chun, Hie‐Won Hann, Zhong Ye, et al.. (2016). Prospective evidence of a circulating microRNA signature as a non-invasive marker of hepatocellular carcinoma in HBV patients. Oncotarget. 0(0). 14 indexed citations
14.
Ternette, Nicola, Peter D. Block, Nicola Borthwick, et al.. (2015). Early Kinetics of the HLA Class I-Associated Peptidome of MVA.HIVconsv-Infected Cells. Journal of Virology. 89(11). 5760–5771. 29 indexed citations
15.
Sinnathamby, Gomathinayagam, Julie Hafner, Peter D. Block, et al.. (2010). ADAM metallopeptidase domain 17 (ADAM17) is naturally processed through major histocompatibility complex (MHC) class I molecules and is a potential immunotherapeutic target in breast, ovarian and prostate cancers. Clinical & Experimental Immunology. 163(3). 324–332. 38 indexed citations
16.
Block, Peter D. & Thomas R. Kelly. (1990). Management of Gallstone Pancreatitis during pregnancy and the Postpartum Period. Obstetrical & Gynecological Survey. 45(1). 51–51. 13 indexed citations
17.
Block, Peter D. & Thomas R. Kelly. (1989). Management of gallstone pancreatitis during pregnancy and the postpartum period.. PubMed. 168(5). 426–8. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026